254 related articles for article (PubMed ID: 26300233)
1. Human Papillomavirus Vaccine: Continuation, Completion, and Missed Opportunities.
Richards MJ; Peters M; Sheeder J
J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):117-21. PubMed ID: 26300233
[TBL] [Abstract][Full Text] [Related]
2. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
3. Missed opportunities for adolescent vaccination, 2006-2011.
Wong CA; Taylor JA; Wright JA; Opel DJ; Katzenellenbogen RA
J Adolesc Health; 2013 Oct; 53(4):492-7. PubMed ID: 23809613
[TBL] [Abstract][Full Text] [Related]
4. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data.
Kepka D; Spigarelli MG; Warner EL; Yoneoka Y; McConnell N; Balch A
Papillomavirus Res; 2016 Dec; 2():128-132. PubMed ID: 27540595
[TBL] [Abstract][Full Text] [Related]
5. Missed opportunities for HPV immunization among young adult women.
Oliveira CR; Rock RM; Shapiro ED; Xu X; Lundsberg L; Zhang LB; Gariepy A; Illuzzi JL; Sheth SS
Am J Obstet Gynecol; 2018 Mar; 218(3):326.e1-326.e7. PubMed ID: 29223597
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents.
Gerend MA; Stephens YP; Kazmer MM; Slate EH; Reyes E
J Adolesc Health; 2019 Jun; 64(6):753-762. PubMed ID: 30777636
[TBL] [Abstract][Full Text] [Related]
7. Effect of decision support on missed opportunities for human papillomavirus vaccination.
Mayne SL; duRivage NE; Feemster KA; Localio AR; Grundmeier RW; Fiks AG
Am J Prev Med; 2014 Dec; 47(6):734-44. PubMed ID: 25455116
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
10. Primary care team- and clinic level factors affecting HPV vaccine uptake.
Chuang E; Cabrera C; Mak S; Glenn B; Hochman M; Bastani R
Vaccine; 2017 Aug; 35(35 Pt B):4540-4547. PubMed ID: 28736202
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.
Iversen OE; Miranda MJ; Ulied A; Soerdal T; Lazarus E; Chokephaibulkit K; Block SL; Skrivanek A; Nur Azurah AG; Fong SM; Dvorak V; Kim KH; Cestero RM; Berkovitch M; Ceyhan M; Ellison MC; Ritter MA; Yuan SS; DiNubile MJ; Saah AJ; Luxembourg A
JAMA; 2016 Dec; 316(22):2411-2421. PubMed ID: 27893068
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.
Irving SA; Groom HC; Stokley S; McNeil MM; Gee J; Smith N; Naleway AL
Acad Pediatr; 2018 Mar; 18(2S):S85-S92. PubMed ID: 29502643
[TBL] [Abstract][Full Text] [Related]
13. Achieving high HPV vaccine completion rates in a pediatric clinic population.
Berenson AB; Rupp R; Dinehart EE; Cofie LE; Kuo YF; Hirth JM
Hum Vaccin Immunother; 2019; 15(7-8):1562-1569. PubMed ID: 30299220
[No Abstract] [Full Text] [Related]
14. Human papillomavirus vaccination completion rates among gynecological providers: an institutional retrospective review.
Elsamadicy EA; Schneiter MK; Hull PC; Khabele D
Hum Vaccin Immunother; 2019; 15(7-8):1851-1855. PubMed ID: 31091165
[No Abstract] [Full Text] [Related]
15. Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017.
Edelstein M; Iyanger N; Hennessy N; Mesher D; Checchi M; Soldan K; McCall M; Nugent J; Crofts J; Lo J; Gilson R; Powell K; Ramsay M; Yarwood J
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808443
[TBL] [Abstract][Full Text] [Related]
16. Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.
Deshmukh U; Oliveira CR; Griggs S; Coleman E; Avni-Singer L; Pathy S; Shapiro ED; Sheth SS
Vaccine; 2018 Jun; 36(25):3599-3605. PubMed ID: 29759380
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
[TBL] [Abstract][Full Text] [Related]
18. Acceptance and compliance with postpartum human papillomavirus vaccination.
Wright JD; Govindappagari S; Pawar N; Cleary K; Burke WM; Devine PC; Lu YS; Tsai WY; Lewin SN; Herzog TJ
Obstet Gynecol; 2012 Oct; 120(4):771-82. PubMed ID: 22996094
[TBL] [Abstract][Full Text] [Related]
19. Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.
Tiro JA; Pruitt SL; Bruce CM; Persaud D; Lau M; Vernon SW; Morrow J; Skinner CS
Vaccine; 2012 Mar; 30(13):2368-75. PubMed ID: 22108490
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus Vaccine Uptake: Increase for American Indian Adolescents, 2013-2015.
Jacobs-Wingo JL; Jim CC; Groom AV
Am J Prev Med; 2017 Aug; 53(2):162-168. PubMed ID: 28256284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
